Inactive Instrument
AS Olainfarm Share Price Deutsche Boerse AG
Stocks
UU4
LV0000100501
Pharmaceuticals
| 07/22/07 | Delisting of AS "Olainfarm” shares from the Baltic Main list | AQ |
| 06/22/06 | Notification about results of final buy-back of shares | AQ |
| 30/21/30 | Notification about final share buy-back | AQ |
| 28/21/28 | Correction: Regarding results of a share buy-back offer | AQ |
| 28/21/28 | On substantial participation (4) - specified | AQ |
| 1 day | -0.24% |
| Manager | Title | Age | Since |
|---|---|---|---|
Juris Hmelnickis
CEO | Chief Executive Officer | 46 | 01/01/2026 |
Janis Leimanis
DFI | Director of Finance/CFO | 56 | - |
| Chief Tech/Sci/R&D Officer | - | 01/01/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 19/06/2021 | |
Janis Buks
CHM | Chairman | - | 01/09/2022 |
Roberts Tavjevs
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.24% | -3.46% | - | - | 15Cr | |
| +0.14% | +0.50% | +23.57% | +74.18% | 4.88TCr | |
| -1.61% | +0.83% | +53.64% | +120.47% | 4.07TCr | |
| -1.16% | +2.64% | +16.46% | +88.00% | 1.23TCr | |
| -0.72% | -0.65% | -10.99% | +13.44% | 1.21TCr | |
| +0.57% | +1.73% | +31.59% | +153.11% | 928.38Cr | |
| -2.36% | -4.19% | +22.25% | +42.78% | 755.42Cr | |
| -0.42% | +2.50% | +27.67% | +224.95% | 734.57Cr | |
| -0.62% | +0.45% | +45.04% | -10.78% | 729.62Cr | |
| -1.29% | -1.44% | -41.24% | +14.36% | 525.5Cr | |
| Average | -0.77% | +0.79% | +18.67% | +80.06% | 1.67TCr | |
| Weighted average by Cap. | -0.72% | +1.17% | +27.74% | +87.37% |
Employees
2,191
Sector
Pharmaceuticals
